Analog Insulin Drug Makers’ Kickbacks to PBMs RICO Complaint

April 27, 2020

This class action alleges that pharmacy benefit managers (PBMs) are taking kickbacks from drug manufacturers in ways that raise the prices of prescription drugs. The drugs at issue in this case are analog insulin drugs, and the case has been brought by a drug wholesaler, which claims that it must pay more for drugs because of the kickbacks. The complaint names as defendants a number of drug makers and three groups of PBMs—CVS Caremark, Express Scripts, and

Case Event File: Analog Insulin Drug Makers’ Kickbacks to PBMs RICO Complaint

Related to: Analog Insulin Drug Makers’ Kickbacks to PBMs RICO Class Action